Two proteins essential for apolipoprotein B mRNA editing are expressed from a single gene through alternative splicing - PubMed (original) (raw)

. 2002 Apr 12;277(15):12703-9.

doi: 10.1074/jbc.M111337200. Epub 2002 Jan 28.

Affiliations

• PMID: 11815617
• DOI: 10.1074/jbc.M111337200

Free article

Two proteins essential for apolipoprotein B mRNA editing are expressed from a single gene through alternative splicing

Geoffrey S C Dance et al. J Biol Chem. 2002.

Free article

Abstract

Apolipoprotein B (apoB) mRNA editing involves site-specific deamination of cytidine to form uridine, resulting in the production of an in-frame stop codon. Protein translated from edited mRNA is associated with a reduced risk of atherosclerosis, and hence the protein factors that regulate hepatic apoB mRNA editing are of interest. A human protein essential for apoB mRNA editing and an eight-amino acid-longer variant of no known function have been recently cloned. We report that both proteins, henceforth referred to as ACF64 and ACF65, supported APOBEC-1 (the catalytic subunit of the editosome) equivalently in editing of apoB mRNA. They are encoded by a single 82-kb gene on chromosome 10. The transcripts are encoded by 15 exons that are expressed from a tissue-specific promoter minimally contained within the -0.33-kb DNA sequence. ACF64 and ACF65 mRNAs are expressed in both liver and intestinal cells in an approximate 1:4 ratio. Exon 11 is alternatively spliced to include or exclude 24 nucleotides of exon 12, thereby encoding ACF65 and ACF64, respectively. Recognition motifs for the serine/arginine-rich (SR) proteins SC35, SRp40, SRp55, and SF2/ASF involved in alternative RNA splicing were predicted in exon 12. Overexpression of these SR proteins in liver cells demonstrated that alternative splicing of a minigene-derived transcript to express ACF65 was enhanced 6-fold by SRp40. The data account for the expression of two editing factors and provide a possible explanation for their different levels of expression.

PubMed Disclaimer

Similar articles

• Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
  Sowden MP, Lehmann DM, Lin X, Smith CO, Smith HC. Sowden MP, et al. J Biol Chem. 2004 Jan 2;279(1):197-206. doi: 10.1074/jbc.M307920200. Epub 2003 Oct 21. J Biol Chem. 2004. PMID: 14570923
• C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme.
  Mukhopadhyay D, Anant S, Lee RM, Kennedy S, Viskochil D, Davidson NO. Mukhopadhyay D, et al. Am J Hum Genet. 2002 Jan;70(1):38-50. doi: 10.1086/337952. Epub 2001 Nov 27. Am J Hum Genet. 2002. PMID: 11727199 Free PMC article.
• Apobec-1 and apolipoprotein B mRNA editing.
  Chan L, Chang BH, Nakamuta M, Li WH, Smith LC. Chan L, et al. Biochim Biophys Acta. 1997 Mar 10;1345(1):11-26. doi: 10.1016/s0005-2760(96)00156-7. Biochim Biophys Acta. 1997. PMID: 9084497 Review.
• Apolipoprotein B messenger RNA editing: an update.
  Chan L. Chan L. Biochimie. 1995;77(1-2):75-8. doi: 10.1016/0300-9084(96)88107-7. Biochimie. 1995. PMID: 7599279 Review.

Cited by

• Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.
  Pan YJ, Huo FC, Kang MJ, Liu BW, Wu MD, Pei DS. Pan YJ, et al. Clin Transl Med. 2022 Nov;12(11):e1113. doi: 10.1002/ctm2.1113. Clin Transl Med. 2022. PMID: 36394206 Free PMC article.
• Host-directed editing of the SARS-CoV-2 genome.
  Mourier T, Sadykov M, Carr MJ, Gonzalez G, Hall WW, Pain A. Mourier T, et al. Biochem Biophys Res Commun. 2021 Jan 29;538:35-39. doi: 10.1016/j.bbrc.2020.10.092. Epub 2020 Nov 5. Biochem Biophys Res Commun. 2021. PMID: 33234239 Free PMC article. Review.
• RNA Editors, Cofactors, and mRNA Targets: An Overview of the C-to-U RNA Editing Machinery and Its Implication in Human Disease.
  Lerner T, Papavasiliou FN, Pecori R. Lerner T, et al. Genes (Basel). 2018 Dec 27;10(1):13. doi: 10.3390/genes10010013. Genes (Basel). 2018. PMID: 30591678 Free PMC article. Review.
• A Novel RNA Editing Sensor Tool and a Specific Agonist Determine Neuronal Protein Expression of RNA-Edited Glycine Receptors and Identify a Genomic APOBEC1 Dimorphism as a New Genetic Risk Factor of Epilepsy.
  Kankowski S, Förstera B, Winkelmann A, Knauff P, Wanker EE, You XA, Semtner M, Hetsch F, Meier JC. Kankowski S, et al. Front Mol Neurosci. 2018 Jan 11;10:439. doi: 10.3389/fnmol.2017.00439. eCollection 2017. Front Mol Neurosci. 2018. PMID: 29375302 Free PMC article.
• Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.
  Rayon-Estrada V, Harjanto D, Hamilton CE, Berchiche YA, Gantman EC, Sakmar TP, Bulloch K, Gagnidze K, Harroch S, McEwen BS, Papavasiliou FN. Rayon-Estrada V, et al. Proc Natl Acad Sci U S A. 2017 Dec 12;114(50):13296-13301. doi: 10.1073/pnas.1714227114. Epub 2017 Nov 22. Proc Natl Acad Sci U S A. 2017. PMID: 29167373 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • BioCyc

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal